Article
Wnt/?-catenin-pathway as a molecular target for future anti-cancer therapeutics
1 Jan 2004
Abstract excerpt
Conventional chemotherapeutic drugs used for the treatment of cancer patients in advanced stages have yielded only limited benefit, regarding survival time not to mention cure of the patients. To improve the clinical outcome of cancer, agents aimed at novel molecular targets are required. Colorectal and many other cancers are caused by hyperactivity of the Wnt/beta-catenin signaling pathway that results in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
